Abstract
Purpose:
To evaluate the use of Densiron Xtra tamponade for inferior and complicated rhegmatogenous retinal detachments (RRD).
Methods:
A retrospective case series was conducted between January 2019 and December 2023. Cases involving ocular trauma or follow-up of less than 12 months were excluded.
Results:
The median patient age was 66 years, and 39.5% of the patients were female. All 123 eyes had inferior RRDs; 42.3% had a history of prior retinal detachment, 85.4% had proliferative vitreoretinopathy grade C/D, and 67.5% had macula-off retinal detachments. The mean tamponade duration was 10.4 weeks, and the mean follow-up duration was 16.3 months. Primary and final anatomic success rates were 75.6% and 96.8%, respectively, with a mean logMAR improvement in visual acuity of 0.4 (P < .001). Complications before oil removal included anterior chamber dispersion (11.4%) and retinal breaks (4.1%). After oil removal, complications included anterior chamber dispersion requiring washout (15.5%), cataract formation (13.8%), posterior capsular opacification (15.5%), hypotony (8.1%), intraocular inflammation (4%), temporary macular thinning (4%), and emulsification (2%).
Conclusions:
Densiron Xtra tamponade demonstrated excellent anatomic and visual outcomes in eyes with inferior and complicated RRDs, with low complication rates.
Keywords
Get full access to this article
View all access options for this article.
